This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Technology / Brunkow, Ramsdell, Sakaguchi Win...
Tech medical breakthrough

Brunkow, Ramsdell, Sakaguchi Win Nobel Medicine

Analysis based on 6 articles · First reported Oct 06, 2025 · Last updated Oct 06, 2025

Sentiment
60
Attention
4
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The Nobel Peace Prize in Physiology or Medicine for discoveries in peripheral immune tolerance is expected to significantly impact the biotechnology and pharmaceutical markets. Companies like Atara Biotherapeutics, Regeneron Pharmaceuticals, AstraZeneca, and Bayer are already investing in therapies based on this research, potentially leading to new treatments for cancer and autoimmune diseases and creating new market opportunities.

Biotechnology Pharmaceuticals Healthcare
Event Summary

Scientists Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi have been awarded the 2025 Nobel Peace Prize in Physiology or Medicine for their groundbreaking discoveries concerning peripheral immune tolerance. Their work has illuminated how the immune system controls itself to prevent autoimmune diseases while still fighting microbes. This research has laid the foundation for a new field of study and is spurring the development of novel treatments for conditions such as cancer and autoimmune diseases. Companies like Atara Biotherapeutics, Regeneron Pharmaceuticals, Quell Therapeutics, AstraZeneca, and Bayer (through its subsidiary MiNK Therapeutics) are actively engaged in clinical trials and partnerships to translate these discoveries into marketable therapies, particularly focusing on regulatory T cells.

Entities Involved
per
Mary E. Brunkow
Mary E. Brunkow is one of the three scientists awarded the 2025 Nobel Peace Prize in Physiology or Medicine for discoveries concerning peripheral immune tolerance, which has laid the foundation for new treatments for cancer and autoimmune diseases.
Importance 90.0 Sentiment 50.0
per
Fred Ramsdell
Fred Ramsdell is one of the three scientists awarded the 2025 Nobel Peace Prize in Physiology or Medicine for discoveries concerning peripheral immune tolerance. He is also a scientific adviser and co-founder of Atara Biotherapeutics, a company involved in developing therapies based on these discoveries.
Importance 90.0 Sentiment 50.0
per
Shimon Sakaguchi
Shimon Sakaguchi is one of the three scientists awarded the 2025 Nobel Peace Prize in Physiology or Medicine for discoveries concerning peripheral immune tolerance, which has laid the foundation for new treatments for cancer and autoimmune diseases.
Importance 90.0 Sentiment 50.0
stock
Atara Biotherapeutics
Atara Biotherapeutics, co-founded by Fred Ramsdell, is actively developing therapies based on the discoveries of regulatory T cells, with support from Regeneron, indicating potential for future market clearance.
Importance 80.0 Sentiment 70.0
stock
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals partly funds and supports Atara Biotherapeutics in developing therapies for diseases like inflammatory bowel disease, leveraging the Nobel-winning research.
Importance 50.0 Sentiment 20.0
stock
AstraZeneca
AstraZeneca has partnered with Quell Therapeutics to develop therapies for inflammatory bowel disease, indicating its interest in the field of immune tolerance.
Importance 50.0 Sentiment 20.0
priv
Quell Therapeutics
Quell Therapeutics has partnered with AstraZeneca to target inflammatory bowel disease, exploring approaches related to regulatory T cells.
Importance 40.0 Sentiment 20.0
stock
MiNK Therapeutics
MiNK Therapeutics, a subsidiary of Bayer, is exploring approaches related to regulatory T cells, contributing to the development of new treatments.
Importance 30.0 Sentiment 10.0
stock
Bayer
Bayer's subsidiary, MiNK Therapeutics, is exploring approaches related to regulatory T cells, showing the company's involvement in this emerging field.
Importance 30.0 Sentiment 10.0
ngo
Institute for Systems Biology
Mary E. Brunkow is a senior program manager at the Institute for Systems Biology, which is her affiliation mentioned in the context of the Nobel Peace Prize.
Importance 20.0 Sentiment 0.0
cnt
Sweden
Sweden is the host nation for the Nobel Peace Prizes, with the king presenting the awards and the Sweden — Sveriges Riksbank funding the economics prize.
Importance 20.0 Sentiment 0.0
cbnk
Sweden — Sveriges Riksbank
The Sweden — Sveriges Riksbank funds the Nobel economics prize, highlighting its role in supporting scientific recognition.
Importance 10.0 Sentiment 0.0
cnt
Norway
Norway hosts the Nobel Peace Prize, a legacy of its historical union with Sweden.
Importance 10.0 Sentiment 0.0
cnt
Japan
Importance 0.0 Sentiment 0.0
cnt
United States
Importance 0.0 Sentiment 0.0
Relationships
Mary E. Brunkow colleague ↔ Fred Ramsdell Mary E. Brunkow is a scientific collaborator and professional colleague of Fred Ramsdell.
Mary E. Brunkow peer ↔ Shimon Sakaguchi Mary E. Brunkow operates as a scientific peer to Shimon Sakaguchi, with both having made independent, foundational disco
Fred Ramsdell scientific peer ↔ Shimon Sakaguchi Fred Ramsdell operates as a scientific peer to Shimon Sakaguchi, with both researchers recognized globally for their par
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.